Similar Articles
391 Liver transplantation for hepatocellular carcinoma: Historical evolution of transplantation criteria
392 Delineation of a SMARCA4-specific competing endogenous RNA network and its function in hepatocellular carcinoma
393 Three-in-one incidence of hepatocellular carcinoma, cholangiocellular carcinoma, and neuroendocrine carcinoma: A case report
394 Elevated procalcitonin levels in the absence of infection in procalcitonin-secretin hepatocellular carcinoma: A case report
395 VCAN, expressed highly in hepatitis B virus-induced hepatocellular carcinoma, is a potential biomarker for immune checkpoint inhibitors
396 Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma
397 Multiple primary malignancies – hepatocellular carcinoma combined with splenic lymphoma: A case report
398 Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma
399 Impact of sarcopenia on tumor response and survival outcomes in patients with hepatocellular carcinoma treated by trans-arterial (chemo)-embolization
400 Early extrahepatic recurrence as a pivotal factor for survival after hepatocellular carcinoma resection: A 15-year observational study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA